Steward Partners Investment Advisory LLC Purchases 14,908 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Steward Partners Investment Advisory LLC lifted its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 218.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 21,738 shares of the company’s stock after acquiring an additional 14,908 shares during the period. Steward Partners Investment Advisory LLC’s holdings in VanEck Pharmaceutical ETF were worth $1,876,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. SBI Securities Co. Ltd. bought a new position in shares of VanEck Pharmaceutical ETF in the fourth quarter worth approximately $29,000. Jones Financial Companies Lllp lifted its stake in shares of VanEck Pharmaceutical ETF by 1,827.0% in the fourth quarter. Jones Financial Companies Lllp now owns 5,704 shares of the company’s stock worth $492,000 after buying an additional 5,408 shares in the last quarter. WT Wealth Management lifted its stake in shares of VanEck Pharmaceutical ETF by 5.6% in the fourth quarter. WT Wealth Management now owns 56,690 shares of the company’s stock worth $4,891,000 after buying an additional 3,030 shares in the last quarter. Blue Chip Partners LLC bought a new position in shares of VanEck Pharmaceutical ETF in the fourth quarter worth approximately $2,139,000. Finally, NTV Asset Management LLC lifted its stake in shares of VanEck Pharmaceutical ETF by 3.6% in the fourth quarter. NTV Asset Management LLC now owns 7,709 shares of the company’s stock worth $665,000 after buying an additional 271 shares in the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of NASDAQ PPH opened at $94.51 on Friday. The company has a market cap of $589.74 million, a PE ratio of 30.55 and a beta of 0.72. The firm’s 50 day moving average price is $88.99 and its 200-day moving average price is $91.37. VanEck Pharmaceutical ETF has a 52-week low of $84.48 and a 52-week high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were given a dividend of $0.411 per share. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.